Inhibrx Biosciences, Inc. SEC filings INBX
Inhibrx Biosciences, Inc. has 158 filings in SEC EDGAR's recent list, going back to Jan 29, 2024. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 28, 2026 | — |
| 4 | Insider transaction | Oct 14, 2026 | Oct 14, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 23, 2026 | Sep 23, 2026 |
| 4/A | Form 4/a | Sep 18, 2026 | Jun 3, 2026 |
| 4/A | Form 4/a | Sep 18, 2026 | Jun 3, 2026 |
| 4/A | Form 4/a | Sep 18, 2026 | Jun 3, 2026 |
| 4/A | Form 4/a | Sep 18, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Sep 17, 2026 | Sep 16, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| 144 | Notice of proposed sale | Sep 15, 2026 | — |
| 144 | Notice of proposed sale | Sep 14, 2026 | — |
| 144 | Notice of proposed sale | Sep 11, 2026 | — |
| 4 | Insider transaction | Sep 10, 2026 | Sep 8, 2026 |
| 144 | Notice of proposed sale | Sep 9, 2026 | — |
| 144 | Notice of proposed sale | Sep 8, 2026 | — |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 8, 2026 | Sep 8, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 3, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jul 16, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | Jun 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 11, 2026 | May 11, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 24, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 21, 2026 | Apr 21, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2026 | Mar 19, 2026 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 23, 2026 | Feb 23, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2025 | Oct 23, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| 4 | Insider transaction | Oct 9, 2025 | Oct 7, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| EFFECT | Filing | Jun 4, 2025 | — |
| POS AM | Filing | Jun 2, 2025 | — |
| 4 | Insider transaction | May 29, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 28, 2025 |
| 424B3 | Prospectus | May 28, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2025 | May 28, 2025 |
| 424B3 | Prospectus | May 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| EFFECT | Filing | Apr 18, 2025 | — |
| POS AM | Filing | Apr 17, 2025 | — |
| ARS | Annual report to shareholders | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| DEF 14A | Proxy statement | Apr 16, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| 3 | Initial insider ownership | Apr 2, 2025 | Apr 1, 2025 |
| 424B3 | Prospectus | Apr 1, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 27, 2025 |
| POS EX | Filing | Mar 17, 2025 | — |
| 424B3 | Prospectus | Mar 17, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 17, 2025 | Mar 17, 2025 |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 26, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 26, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 4, 2025 | — |
| 424B3 | Prospectus | Jan 21, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 21, 2025 | Jan 21, 2025 |
| 424B3 | Prospectus | Jan 13, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 16, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 19, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 424B3 | Prospectus | Nov 14, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 424B3 | Prospectus | Nov 4, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 4, 2024 | Nov 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 10, 2024 |
| 4 | Insider transaction | Sep 10, 2024 | Sep 6, 2024 |
| 4 | Insider transaction | Sep 3, 2024 | Aug 29, 2024 |
| 4 | Insider transaction | Sep 3, 2024 | Aug 29, 2024 |
| 4 | Insider transaction | Aug 30, 2024 | Aug 28, 2024 |
| 4 | Insider transaction | Aug 26, 2024 | Aug 22, 2024 |
| 4 | Insider transaction | Aug 22, 2024 | Aug 20, 2024 |
| 424B3 | Prospectus | Aug 14, 2024 | — |
| 424B3 | Prospectus | Aug 13, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2024 | Aug 13, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 24, 2024 |
| EFFECT | Filing | Jun 18, 2024 | — |
| 424B3 | Prospectus | Jun 18, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2024 | Jun 17, 2024 |
| CORRESP | Letter to the SEC | Jun 14, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2024 | — |
| S-1 | Registration statement | Jun 11, 2024 | — |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| SC 13G | Ownership over 5% (passive) | Jun 7, 2024 | — |
| 3 | Initial insider ownership | Jun 7, 2024 | May 29, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| SC 13D | Ownership over 5% (active) | Jun 3, 2024 | — |
| SC 13D | Ownership over 5% (active) | Jun 3, 2024 | — |
| SC 13G | Ownership over 5% (passive) | May 31, 2024 | — |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 30, 2024 |
| S-8 | Employee stock plan registration | May 30, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
May 30, 2024 | May 29, 2024 |
| 3 | Initial insider ownership | May 24, 2024 | May 24, 2024 |
| 3 | Initial insider ownership | May 24, 2024 | May 24, 2024 |
| 3 | Initial insider ownership | May 24, 2024 | May 24, 2024 |
| 3 | Initial insider ownership | May 24, 2024 | May 24, 2024 |
| 3 | Initial insider ownership | May 24, 2024 | May 24, 2024 |
| 3 | Initial insider ownership | May 24, 2024 | May 24, 2024 |
| 3 | Initial insider ownership | May 24, 2024 | May 24, 2024 |
| 3 | Initial insider ownership | May 24, 2024 | May 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2024 | May 24, 2024 |
| SEC STAFF ACTION | Filing | May 24, 2024 | — |
| CERT | Filing | May 24, 2024 | — |
| CORRESP | Letter to the SEC | May 22, 2024 | — |
| 10-12B/A | Filing | May 15, 2024 | — |
| 10-12B/A | Filing | May 8, 2024 | — |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| 10-12B | Filing | Apr 25, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2024 | — |
| DRSLTR | Filing | Mar 4, 2024 | — |
| DRS/A | Filing | Mar 4, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 29, 2024 | — |
| DRS | Filing | Jan 29, 2024 | — |
Showing 158 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- INBX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2007919
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.